Search Results - "Carvalho, Jonatan C. S."

The turning point of COVID‐19 severity is associated with a unique circulating neutrophil gene signature by Fuzo, Carlos A., Fraga‐Silva, Thais F. C., Maruyama, Sandra R., Bastos, Víctor A. F., Rogerio, Luana A., Takamiya, Nayore T., Silva‐Neto, Pedro V., Pimentel, Vinícius E., Toro, Diana M., Pérez, Malena M., Carvalho, Jonatan C. S., Carmona‐Garcia, Ingryd, Oliveira, Camilla N. S., Degiovani, Augusto M., Ostini, Fátima M., Constant, Leticia F., Amorim, Alessandro P., Vilar, Fernando C., Feitosa, Marley R., Parra, Rogerio S., Rocha, José J. R., Feres, Omar, Gaspar, Gilberto G., Viana, Angelina L., Fernandes, Ana P. M., Santos, Isabel K. F. M., Russo, Elisa M. S., Cardoso, Cristina R. B., Sorgi, Carlos A., Faccioli, Lúcia H., Bonato, Vânia L. D., Dias‐Baruffi, Marcelo

“…COVID‐19 has a broad spectrum of clinical manifestations associated with the host immune response heterogeneity. Despite the advances in COVID‐19 research, it…”
Get full text

The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule by Cordeiro, Jéssica F. C., Fernandes, Talita M., Toro, Diana M., da Silva-Neto, Pedro V., Pimentel, Vinícius E., Pérez, Malena M., de Carvalho, Jonatan C. S., Fraga-Silva, Thais F. C., Oliveira, Camilla N. S., Argolo, Jamille G. M., Degiovani, Augusto M., Ostini, Fátima M., Puginna, Enrico F., da Silva, João S., Santos, Isabel K. F. M., Bonato, Vânia L. D., Cardoso, Cristina R. B., Dias-Baruffi, Marcelo, Faccioli, Lúcia H., Donadi, Eduardo A., Sorgi, Carlos A., Fernandes, Ana P. M.

“…The non-classical histocompatibility antigen G (HLA-G) is an immune checkpoint molecule that has been implicated in viral disorders. We evaluated the plasma…”
Get full text

Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity by Pérez, Malena M., Pimentel, Vinícius E., Fuzo, Carlos A., da Silva-Neto, Pedro V., Toro, Diana M., Fraga-Silva, Thais F. C., Gardinassi, Luiz G., Oliveira, Camilla N. S., Souza, Camila O. S., Torre-Neto, Nicola T., de Carvalho, Jonatan C. S., De Leo, Thais C., Nardini, Viviani, Feitosa, Marley R., Parra, Rogerio S., da Rocha, José J. R., Feres, Omar, Vilar, Fernando C., Gaspar, Gilberto G., Constant, Leticia F., Ostini, Fátima M., Degiovani, Augusto M., Amorim, Alessandro P., Viana, Angelina L., Fernandes, Ana P. M., Maruyama, Sandra R., Russo, Elisa M. S., Santos, Isabel K. F. M., Bonato, Vânia L. D., Cardoso, Cristina R. B., Sorgi, Carlos A., Dias-Baruffi, Marcelo, Faccioli, Lúcia H.

“…Lipid and cholinergic mediators are inflammatory regulators, but their role in the immunopathology of COVID-19 is still unclear. Here, we used human blood and…”
Get full text

Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men by Duarte-Silva, Murillo, Oliveira, Camilla N.S., Fuzo, Carlos, Silva-Neto, Pedro V., Toro, Diana M., Pimentel, Vinícius E., Pérez, Malena M., Fraga-Silva, Thais F.C., Carvalho, Jonatan C.S., Neto, Firmino M.S., Júnior, Ronaldo B.M., Arruda, Eurico, Vilar, Fernando C., Degiovani, Augusto M., Ostini, Fátima M., Feitosa, Marley R., Parra, Rogerio S., Gaspar, Gilberto G., Rocha, José J.R., Feres, Omar, Fernandes, Ana P.M., Maruyama, Sandra R., Russo, Elisa M.S., Bonato, Vânia L.D., Santos, Isabel K.F.M., Sorgi, Carlos A., Dias-Baruffi, Marcelo, Faccioli, Lúcia H., Cardoso, Cristina R.B.

“…•Lowering testosterone is a hallmark of the worst COVID-19 prognosis in men.•Reduced testosterone in men with COVID-19 is partially dependent on age and…”
Get full text

Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19 by Toro, Diana Mota, da Silva-Neto, Pedro V, de Carvalho, Jonatan C S, Fuzo, Carlos A, Pérez, Malena M, Pimentel, Vinícius E, Fraga-Silva, Thais F C, Oliveira, Camilla N S, Caruso, Glaucia R, Vilela, Adriana F L, Nobre-Azevedo, Pedro, Defelippo-Felippe, Thiago V, Argolo, Jamille G M, Degiovani, Augusto M, Ostini, Fátima M, Feitosa, Marley R, Parra, Rogerio S, Vilar, Fernando C, Gaspar, Gilberto G, Rocha, José J R da, Feres, Omar, Costa, Gabriel P, Maruyama, Sandra R C, Russo, Elisa M S, Fernandes, Ana Paula M, Santos, Isabel K F M, Malheiro, Adriana, Sadikot, Ruxana T, Bonato, Vânia L D, Cardoso, Cristina R B, Dias-Baruffi, Marcelo, Trapé, Átila A, Faccioli, Lúcia H, Sorgi, Carlos A, ImmunoCovid Consortium Group

“…SARS-CoV-2 infection triggers distinct patterns of disease development characterized by significant alterations in host regulatory responses. Severe cases…”
Get full text

sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity by da Silva-Neto, Pedro V, de Carvalho, Jonatan C S, Pimentel, Vinícius E, Pérez, Malena M, Toro, Diana M, Fraga-Silva, Thais F C, Fuzo, Carlos A, Oliveira, Camilla N S, Rodrigues, Lilian C, Argolo, Jamille G M, Carmona-Garcia, Ingryd, Neto, Nicola T, Souza, Camila O S, Fernandes, Talita M, Bastos, Victor A F, Degiovani, Augusto M, Constant, Leticia F, Ostini, Fátima M, Feitosa, Marley R, Parra, Rogerio S, Vilar, Fernando C, Gaspar, Gilberto G, da Rocha, José J R, Feres, Omar, Frantz, Fabiani G, Gerlach, Raquel F, Maruyama, Sandra R, Russo, Elisa M S, Viana, Angelina L, Fernandes, Ana P M, Santos, Isabel K F M, Bonato, Vânia L D, Boechat, Antonio L, Malheiro, Adriana, Sadikot, Ruxana T, Dias-Baruffi, Marcelo, Cardoso, Cristina R B, Faccioli, Lúcia H, Sorgi, Carlos A, On Behalf Of The Imunocovid Study Group

“…Uncontrolled inflammatory responses play a critical role in coronavirus disease (COVID-19). In this context, because the triggering-receptor expressed on…”
Get full text

Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress by da Silva-Neto, Pedro V, do Valle, Valéria B, Fuzo, Carlos A, Fernandes, Talita M, Toro, Diana M, Fraga-Silva, Thais F C, Basile, Patrícia A, de Carvalho, Jonatan C S, Pimentel, Vinícius E, Pérez, Malena M, Oliveira, Camilla N S, Rodrigues, Lilian C, Bastos, Victor A F, Tella, Sandra O C, Martins, Ronaldo B, Degiovani, Augusto M, Ostini, Fátima M, Feitosa, Marley R, Parra, Rogerio S, Vilar, Fernando C, Gaspar, Gilberto G, Rocha, José J R da, Feres, Omar, Arruda, Eurico, Maruyama, Sandra R, Russo, Elisa M S, Viana, Angelina L, Santos, Isabel K F M, Bonato, Vânia L D, Cardoso, Cristina R B, Tanus-Santos, Jose E, Donadi, Eduardo A, Faccioli, Lucia H, Dias-Baruffi, Marcelo, Fernandes, Ana P M, Gerlach, Raquel F, Sorgi, Carlos A, On Behalf Of The Immunocovid Study Group

“…Patients with COVID-19 predominantly have a respiratory tract infection and acute lung failure is the most severe complication. While the molecular basis of…”
Get full text

The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity by Siekman, Sterre L, Pongracz, Tamas, Wang, Wenjun, Nouta, Jan, Kremsner, Peter G, da Silva-Neto, Pedro Vieira, Esen, Meral, Kreidenweiss, Andrea, Held, Jana, Trapé, Átila Alexandre, Fendel, Rolf, de Miranda Santos, Isabel Kinney Ferreira, Wuhrer, Manfred

“…Immunoglobulin G (IgG) antibodies play an important role in the immune response against viruses such as SARS-CoV-2. As the effector functions of IgG are…”
Get full text

The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19 by de Carvalho, Jonatan C S, da Silva-Neto, Pedro V, Toro, Diana M, Fuzo, Carlos A, Nardini, Viviani, Pimentel, Vinícius E, Pérez, Malena M, Fraga-Silva, Thais F C, Oliveira, Camilla N S, Degiovani, Augusto M, Ostini, Fátima M, Feitosa, Marley R, Parra, Rogerio S, da Rocha, José J R, Feres, Omar, Vilar, Fernando C, Gaspar, Gilberto G, Santos, Isabel K F M, Fernandes, Ana P M, Maruyama, Sandra R, Russo, Elisa M S, Bonato, Vânia L D, Cardoso, Cristina R B, Dias-Baruffi, Marcelo, Faccioli, Lúcia H, Sorgi, Carlos A, On Behalf Of The ImmunoCovid Study Group

“…COVID-19 is associated with a dysregulated immune response. Currently, several medicines are licensed for the treatment of this disease. Due to their…”
Get full text